Artemether/Lumefantrine

BreastfeedingPediatric
  • TRADE NAME: Coartem (Novartis)
  • INDICATIONS: Acute, uncomplicated malaria infections due to Plasmodium falciparum in patients of 5kg bodyweight and above
  • CLASS: Antimalarial
  • HALF-LIFE: ~2 hours (artemether); 3–6 days (lumefantrine)

Artemether/Lumefantrine tablets should not be used to treat severe malaria or to prevent malaria.

Our database has 86 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
OTIC
RENAL
RESPIRATORY
OTHER


Page last updated 06/12/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top